Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Stewart Tepper, MD. [LISTEN TIME: 26 minutes]
Stewart Tepper, MD
Advertisement
Articles by Stewart Tepper, MD
The professor of neurology at the Geisel School of Medicine at Dartmouth broke down the FDA approval of STS101, a new DHE nasal powder, and its implications for acute migraine care. [WATCH TIME: 7 minutes]
Advertisement
Latest Updated Articles
Special Episode: Breaking Down the FDA’s Latest Migraine Therapy Approvals with Stewart Tepper, MDPublished: July 18th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS
2
Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation
3
ALS Qualitative Study Highlights Complexities of Decision-Making Process for Medical Aid in Dying (MAID)
4
Ensuring a Comprehensive Diagnosis of CIDP and the Role of EMG
5
